Achieve Life Sciences ACHV
NASDAQ ACHV
$6.78 +0.06 (+0.89%)
At close: Nov 9, 2026 · 4:00 PM EST

Achieve Life Sciences (ACHV) Non-Current Deferred Tax Liability (2016)

Updated

Achieve Life Sciences (ACHV) recorded Non-Current Deferred Tax Liability of $124,000 in Q4 2016.

Analysis

Achieve Life Sciences (ACHV) Non-Current Deferred Tax Liability (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Achieve Life Sciences 696.42 Mn 509.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 124,000.00
API Access

Achieve Life Sciences Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ACHV&period=max&api_key=YOUR_API_KEY